These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 12775949

  • 1. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W, Köenig W.
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [Abstract] [Full Text] [Related]

  • 2. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W, Wieland H.
    Herz; 2000 Mar; 25(2):117-25. PubMed ID: 10829251
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S, Ferri N, Arnaboldi L, Bernini F, Paoletti R, Corsini A.
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [Abstract] [Full Text] [Related]

  • 5. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP, Deanfield JE.
    Circulation; 2004 Jun 01; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Anti-atherosclerotic actions of HMG-CoA reductase inhibitors].
    Gmiński J, Wojakowski W.
    Przegl Lek; 1997 Jun 01; 54(11):782-7. PubMed ID: 9501689
    [Abstract] [Full Text] [Related]

  • 9. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
    Schönbeck U, Libby P.
    Circulation; 2004 Jun 01; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The promise of statins].
    Capurso A.
    Ital Heart J Suppl; 2001 Mar 01; 2(3):224-9. PubMed ID: 11307780
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L, Uzick M.
    Altern Med Rev; 2001 Jun 01; 6(3):248-71. PubMed ID: 11410071
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pleiotropic effects and cholesterol-lowering therapy.
    Shaw SM, Fildes JE, Yonan N, Williams SG.
    Cardiology; 2009 Jun 01; 112(1):4-12. PubMed ID: 18577880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M.
    Am J Cardiovasc Drugs; 2010 Jun 01; 10 Suppl 1():3-9. PubMed ID: 21391728
    [Abstract] [Full Text] [Related]

  • 20. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D, Enseleit F, Ruschitzka F.
    Herz; 2004 Dec 01; 29(8):760-8. PubMed ID: 15599672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.